adr_usa_0438|IPHA|Short Name|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
adr_usa_0438|IPHA|Long Name|Innate Pharma SA Total Current Assets (Quarterly) (USD)|Innate Pharma SA Cash and Short Term Investments (Quarterly) (USD)|Innate Pharma SA Inventories (Quarterly) (USD)|Innate Pharma SA Net PP&E (Quarterly) (USD)|Innate Pharma SA Goodwill and Intangibles (Quarterly) (USD)|Innate Pharma SA Total Liabilities (Quarterly) (USD)|Innate Pharma SA Total Current Liabilities (Quarterly) (USD)|Innate Pharma SA Total Long Term Liabilities (Quarterly) (USD)|Innate Pharma SA Total Deposits (Quarterly) (USD)|Innate Pharma SA Book Value (Quarterly) (USD)|Innate Pharma SA Retained Earnings (Quarterly) (USD)|Innate Pharma SA Treasury Stock (Quarterly) (USD)|Innate Pharma SA EV to Revenues|Innate Pharma SA EV to Earnings|Innate Pharma SA EV to Free Cash Flow|Innate Pharma SA EV to Assets (Quarterly)|Innate Pharma SA PS Ratio|Innate Pharma SA PE Ratio|Innate Pharma SA Price to Book Value|Innate Pharma SA PEG Ratio|Innate Pharma SA Debt to Equity Ratio|Innate Pharma SA Dividend Yield|Innate Pharma SA Shareholder Yield (TTM)|Innate Pharma SA Percent of Shares Outstanding Short|Innate Pharma SA Total Receivables (Quarterly) (USD)|Innate Pharma SA Total Payables (Quarterly) (USD)|Innate Pharma SA Total Capital Stock (Quarterly) (USD)|Innate Pharma SA Return on Invested Capital|Innate Pharma SA Quality Ratio Score|Innate Pharma SA Momentum Score|Innate Pharma SA Beta (1Y)|Innate Pharma SA Sustainable Growth Rate (TTM)|Innate Pharma SA Institutional Investor Ownership Percentage|Innate Pharma SA Average Diluted Shares Outstanding (Quarterly)|Innate Pharma SA Total Employees (Annual)|Innate Pharma SA EPS Diluted (Quarterly) (USD)|Innate Pharma SA Dividend Per Share (Quarterly) (USD)|Innate Pharma SA Revenue (Quarterly) (USD)|Innate Pharma SA Gross Profit (Quarterly) (USD)|Innate Pharma SA SG&A Expense (Quarterly) (USD)|Innate Pharma SA Pre-Tax Income (Quarterly) (USD)|Innate Pharma SA Net Income (Quarterly) (USD)|Innate Pharma SA Net Interest Income (Quarterly) (USD)|Innate Pharma SA Price (USD)|Innate Pharma SA Total Return Price (USD)|Innate Pharma SA Enterprise Value (USD)|Innate Pharma SA 30-Day Average Daily Volume|Innate Pharma SA 1 Year Price Returns (Daily)||
adr_usa_0438|IPHA|Unit|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
adr_usa_0438|IPHA|200812|||||||||||||||||||||||||||||||||||89|||||||||||||||
adr_usa_0438|IPHA|200912|80.4604|70.3474||11.3585||24.4487|13.249|11.1998||67.3845|-90.4089||||||||||0.1603||||10.1115|11.9677|2.6198||||||||80|||||||||||||||
adr_usa_0438|IPHA|201006|58.2224|47.8628||9.3752||18.0803|8.9057|9.1747||49.5307|-76.8897||||||||||0||||10.2373|7.9702|2.3038|-28.8599||||-31.5264|||81|||||||||||||||
adr_usa_0438|IPHA|201012|54.0815|45.9913||9.7553||19.2764|9.8071|9.4693||44.5749|-18.1646||||||||||0.1987||||8.0901||2.5056|-29.7636||||-33.387|||86|||||||||||||||
adr_usa_0438|IPHA|201106|48.8005|42.9301||9.8009||19.2428|11.4122|7.8306||40.8063|-118.5377||||||||||0||||5.8704|8.3923|2.7275|-35.3381||||-37.6582|||78|||||||||||||||
adr_usa_0438|IPHA|201112|68.6185|60.3688||8.3443||43.3718|20.0694|23.3024||34.4874|-108.4037||||||||||0.0909||||7.4972|7.5814|2.4403|-22.5072||||-24.7587||||||||||||||||||
adr_usa_0438|IPHA|201206|60.0326|46.95||8.5716||38.7764|22.0287|16.7477||30.6638|-106.8432||||||||||0|||||20.4314|2.3438|-13.6348||||-14.038||||||||||||||||||
adr_usa_0438|IPHA|201212|54.2185|43.1347||9.0247||32.9712|20.3189|12.6524||30.8989|-115.1488||||||||||0.0321||||9.5604|8.6267|2.5088|-12.3479||||-12.878||||||||||||||||||
adr_usa_0438|IPHA|201306|45.8025|32.2418||8.5169||26.5074|19.4866|7.0208||27.9958|-116.5028||||||||||0.029||||12.0997|7.9865|2.4854|-14.9811||||-15.2824||||||||||||||||||
adr_usa_0438|IPHA|201312|68.1459|57.0976||8.6415|0|21.536|12.8117|8.7243||55.6297|-124.2286||||||||||0.0405||||9.7517|10.2267|3.158|-9.6361||||-9.9771||||||||||||||||||
adr_usa_0438|IPHA|201406|124.094|107.661||8.2595|8.6592|25.1672|17.3744|7.7929||115.9942|-135.0698||||||||||0.0176||||13.7167|15.5612|3.6127|-19.3016||||-19.7956||||||||||||||||||
adr_usa_0438|IPHA|201412|96.4474|84.1948||7.2122|6.5203|19.5341|13.1026|6.4315||90.7467|-133.1882||||||||||0.0201||||10.4395|11.4756|3.22|-28.6554||||-29.3239||||||||||||||||||
adr_usa_0438|IPHA|201506|330.2551|312.8423||6.5232|5.3074|264.591|64.8666|199.7244||77.59|-130.6675||||||||||0.0217||||13.3302|11.2048|3.0014|-22.8896||||-23.3365||||||||||||||||||
adr_usa_0438|IPHA|201512|275.6494|257.9204||6.8922|10.64|255.7108|65.7762|189.9346||78.7909|-127.0754||||||||||0.0208||||10.8761|20.3693|2.9432|-8.8298||||-9.0136||||||||||||||||||
adr_usa_0438|IPHA|201606|250.133|226.8362||8.6985|11.1178|237.0975|88.1407|148.9568||76.9784|-132.819||||||||||0.0217||||14.5961|15.1523|2.9978|-2.6914||||-2.7489||||||||||||||||||
adr_usa_0438|IPHA|201612|243.2293|208.9878||9.6138|9.5937|206.5775|80.8104|125.7672||91.0944|-109.5165||||||||||0.0165||||27.0147|21.4233|2.8501|16.0617||||16.375||||||||||||||||||
adr_usa_0438|IPHA|201706|223.9514|196.1674||11.2495|8.8312|203.0208|86.9703|116.0504||78.8278|-145.2266||||||||||0.0174||||20.0601|20.7991|3.0898|-10.3131||||-10.503||||||||||||||||||
adr_usa_0438|IPHA|201712|164.9839|139.2972||12.8716|55.4165|202.8297|88.6686|114.1611||103.1214|-182.3304||||||||||0.0331||||18.0963|29.581|3.4551|-59.252||||-60.6185||||||||||||||||||
adr_usa_0438|IPHA|201806|141.7999|112.0148||12.3414|51.9173|160.4184|77.7158|82.7025||100.788|-173.6558||||||||||0.0112||||24.9903|30.3332|3.3299|-49.3895||||-50.4232||||||||||||||||||
adr_usa_0438|IPHA|201812|365.6396|191.6387||11.6861|96.6927|324.8401|225.0475|99.7927||191.3058|-154.1874||||||||||0.0145||||167.7381|104.8442|3.657|1.9947||||2.0316||||||||||||||||||
adr_usa_0438|IPHA|201906|246.3629|187.5527||12.9595|99.9207|194.7556|107.5022|87.2534||206.0994|-138.3399||||||||||0.012||||50.31|32.0441|3.6418|21.1679||||21.4384||||||||||||||||||
adr_usa_0438|IPHA||||||||||||||||||||||||||||||||||0.0549||||||||||||||||6.05|6.05
adr_usa_0438|IPHA|201912|266.158|245.166||13.0746|108.6206|206.0497|136.4614|69.5883||243.5429|-174.378||3.6247|-12.2878|-8.2716|0.6224|5.6734|11.1174|2.084||0.0717|0|-15.474|0.0503|14.7202|55.4529|4.4146|-10.2949||||-10.6596|31.1123||235|||||||||6.44|6.44|279.8454|18581.6||7.3|7.3
adr_usa_0438|IPHA|202003|||||||||||||3.8697||-8.8307||5.8848||2.1617|||0||0.0539|||||||||23.372|||||||||||6.68|6.68|298.7601|25813.2||5.36|5.36
adr_usa_0438|IPHA|202006|184.0961|166.1599||13.9841|107.0855|140.9234|92.611|48.3124||233.6659|-186.7548||7.5881|-8.0657|-3.8504|1.0557|9.7739||2.3129||0.0906|0|-14.6584|0.0176|17.9362|29.8532|4.4379|-20.3046||||-21.5258|13.3627|||||||||||6.85|6.85|395.4553|8358.5||6.2|6.2
adr_usa_0438|IPHA|202009|||||||||||||3.0359||-1.5405||5.4791||1.2976|||0||0.0287|||||||||13.3519|||||||||||3.84|3.84|158.2164|11172.6333||3.85|3.85